Evidence map›Paper›PMID 35812430›Full record

ArticleFrontiers in immunology2022

Natural Exposure- and Vaccination-Induced Profiles of

Susan Raju Paul, Anja Scholzen, Ghazel Mukhtar, Stephanie Wilkinson, Peter Hobson, Richard K Dzeng, Jennifer Evans, Jennifer Robson, Rowland Cobbold, Stephen Graves and 3 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.1field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Cytometry profiling ofFrontiers in immunology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Susan Raju PaulVaccine and Immunotherapy Center, Massachusetts General Hospital, Boston, MA, United States.
Anja ScholzenInnatOss Laboratories B.V., Oss, Netherlands.
Ghazel MukhtarVaccine and Immunotherapy Center, Massachusetts General Hospital, Boston, MA, United States.
Stephanie WilkinsonSullivan Nicolaides Pathology, Brisbane, QLD, Australia.
Peter HobsonSullivan Nicolaides Pathology, Brisbane, QLD, Australia.
Richard K DzengVaccine and Immunotherapy Center, Massachusetts General Hospital, Boston, MA, United States.
Jennifer EvansSullivan Nicolaides Pathology, Brisbane, QLD, Australia.
Jennifer RobsonSullivan Nicolaides Pathology, Brisbane, QLD, Australia.
Rowland CobboldSchool of Veterinary Science, University of Queensland, Gatton, QLD, Australia.
Stephen GravesAustralian Rickettsial Reference Laboratory, Geelong, VIC, Australia.
Mark C PoznanskyVaccine and Immunotherapy Center, Massachusetts General Hospital, Boston, MA, United States.
Anja GarritsenInnatOss Laboratories B.V., Oss, Netherlands.
Ann E SluderVaccine and Immunotherapy Center, Massachusetts General Hospital, Boston, MA, United States.
Massachusetts General Hospital · USSullivan Nicolaides Pathology · AUUniversity of Queensland · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Q fever is a zoonotic disease caused by the highly infectious Gram-negative coccobacillus,

Indexed as

Coxiella burnetiiQ FeverAustraliaChemokine CXCL10CytokinesHumansInterleukin-2Interleukin-6Retrospective StudiesTumor Necrosis Factor-alphaVaccinationChemokine CXCL10CytokinesInterleukin-2Interleukin-6Tumor Necrosis Factor-alphaCoxiella burnetiicytokines signaturehumanIFNgammaIL-2infectionQ fevervaccination

Identifiers

PMID35812430
PMCPMC9259895
OpenAlexW4283317466

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.